These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

892 related articles for article (PubMed ID: 21292775)

  • 1. Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1.
    Rajkumar SV; Harousseau JL; Durie B; Anderson KC; Dimopoulos M; Kyle R; Blade J; Richardson P; Orlowski R; Siegel D; Jagannath S; Facon T; Avet-Loiseau H; Lonial S; Palumbo A; Zonder J; Ludwig H; Vesole D; Sezer O; Munshi NC; San Miguel J;
    Blood; 2011 May; 117(18):4691-5. PubMed ID: 21292775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2.
    Munshi NC; Anderson KC; Bergsagel PL; Shaughnessy J; Palumbo A; Durie B; Fonseca R; Stewart AK; Harousseau JL; Dimopoulos M; Jagannath S; Hajek R; Sezer O; Kyle R; Sonneveld P; Cavo M; Rajkumar SV; San Miguel J; Crowley J; Avet-Loiseau H;
    Blood; 2011 May; 117(18):4696-700. PubMed ID: 21292777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3.
    Dimopoulos M; Kyle R; Fermand JP; Rajkumar SV; San Miguel J; Chanan-Khan A; Ludwig H; Joshua D; Mehta J; Gertz M; Avet-Loiseau H; Beksaç M; Anderson KC; Moreau P; Singhal S; Goldschmidt H; Boccadoro M; Kumar S; Giralt S; Munshi NC; Jagannath S;
    Blood; 2011 May; 117(18):4701-5. PubMed ID: 21292778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling: Summary and Recommendations from the Organizing Committee.
    Holstein SA; Avet-Loiseau H; Hahn T; Ho CM; Lohr JG; Munshi NC; Paiva B; Pasquini MC; Tario JD; Usmani SZ; Wallace PK; Weisel K; McCarthy PL
    Biol Blood Marrow Transplant; 2018 Apr; 24(4):641-648. PubMed ID: 29242112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinically relevant end points and new drug approvals for myeloma.
    Anderson KC; Kyle RA; Rajkumar SV; Stewart AK; Weber D; Richardson P;
    Leukemia; 2008 Feb; 22(2):231-9. PubMed ID: 17972944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in the management of multiple myeloma: clinical impact based on resource-stratification. Consensus statement of the Asian Myeloma Network at the 16th international myeloma workshop.
    Tan D; Lee JH; Chen W; Shimizu K; Hou J; Suzuki K; Nawarawong W; Huang SY; Sang Chim C; Kim K; Kumar L; Malhotra P; Chng WJ; Durie B;
    Leuk Lymphoma; 2018 Oct; 59(10):2305-2317. PubMed ID: 29390932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardizing definitions and reporting guidelines for the infertility core outcome set: an international consensus development study.
    Duffy JMN; Bhattacharya S; Bhattacharya S; Bofill M; Collura B; Curtis C; Evers JLH; Giudice LC; Farquharson RG; Franik S; Hickey M; Hull ML; Jordan V; Khalaf Y; Legro RS; Lensen S; Mavrelos D; Mol BW; Niederberger C; Ng EHY; Puscasiu L; Repping S; Sarris I; Showell M; Strandell A; Vail A; van Wely M; Vercoe M; Vuong NL; Wang AY; Wang R; Wilkinson J; Youssef MA; Farquhar CM;
    Fertil Steril; 2021 Jan; 115(1):201-212. PubMed ID: 33272619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple Myeloma.
    Holstein SA; Asimakopoulos F; Azab AK; Bianchi G; Bhutani M; Crews LA; Cupedo T; Giles H; Gooding S; Hillengass J; John L; Kaiser S; Lee L; Maclachlan K; Pasquini MC; Pichiorri F; Shah N; Shokeen M; Shy BR; Smith EL; Verona R; Usmani SZ; McCarthy PL
    Transplant Cell Ther; 2022 Aug; 28(8):446-454. PubMed ID: 35605882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trials referral resource. Multiple myeloma and Waldenström's macroglobulinemia phase III trials.
    Cheson BD; Phillips PH
    Oncology (Williston Park); 1994 Jul; 8(7):45, 48-50. PubMed ID: 7917838
    [No Abstract]   [Full Text] [Related]  

  • 12. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma.
    Kumar S; Paiva B; Anderson KC; Durie B; Landgren O; Moreau P; Munshi N; Lonial S; Bladé J; Mateos MV; Dimopoulos M; Kastritis E; Boccadoro M; Orlowski R; Goldschmidt H; Spencer A; Hou J; Chng WJ; Usmani SZ; Zamagni E; Shimizu K; Jagannath S; Johnsen HE; Terpos E; Reiman A; Kyle RA; Sonneveld P; Richardson PG; McCarthy P; Ludwig H; Chen W; Cavo M; Harousseau JL; Lentzsch S; Hillengass J; Palumbo A; Orfao A; Rajkumar SV; Miguel JS; Avet-Loiseau H
    Lancet Oncol; 2016 Aug; 17(8):e328-e346. PubMed ID: 27511158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group.
    Laubach J; Garderet L; Mahindra A; Gahrton G; Caers J; Sezer O; Voorhees P; Leleu X; Johnsen HE; Streetly M; Jurczyszyn A; Ludwig H; Mellqvist UH; Chng WJ; Pilarski L; Einsele H; Hou J; Turesson I; Zamagni E; Chim CS; Mazumder A; Westin J; Lu J; Reiman T; Kristinsson S; Joshua D; Roussel M; O'Gorman P; Terpos E; McCarthy P; Dimopoulos M; Moreau P; Orlowski RZ; Miguel JS; Anderson KC; Palumbo A; Kumar S; Rajkumar V; Durie B; Richardson PG
    Leukemia; 2016 May; 30(5):1005-17. PubMed ID: 26710887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline.
    Mikhael J; Ismaila N; Cheung MC; Costello C; Dhodapkar MV; Kumar S; Lacy M; Lipe B; Little RF; Nikonova A; Omel J; Peswani N; Prica A; Raje N; Seth R; Vesole DH; Walker I; Whitley A; Wildes TM; Wong SW; Martin T
    J Clin Oncol; 2019 May; 37(14):1228-1263. PubMed ID: 30932732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creating Equitable and Inclusive Clinical Trials for Multiple Myeloma.
    Hartley-Brown M; Cole CE; Price P; Andreini M; Mulligan G; Young AQ; Cho HJ
    Clin Lymphoma Myeloma Leuk; 2024 Jan; 24(1):32-39. PubMed ID: 37783639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple myeloma: new staging systems for diagnosis, prognosis and response evaluation.
    Rajkumar SV; Buadi F
    Best Pract Res Clin Haematol; 2007 Dec; 20(4):665-80. PubMed ID: 18070712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving outcome reporting in clinical trial reports and protocols: study protocol for the Instrument for reporting Planned Endpoints in Clinical Trials (InsPECT).
    Butcher NJ; Monsour A; Mew EJ; Szatmari P; Pierro A; Kelly LE; Farid-Kapadia M; Chee-A-Tow A; Saeed L; Monga S; Ungar W; Terwee CB; Vohra S; Fergusson D; Askie LM; Williamson PR; Chan AW; Moher D; Offringa M
    Trials; 2019 Mar; 20(1):161. PubMed ID: 30841935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network.
    Ludwig H; Boccadoro M; Moreau P; San-Miguel J; Cavo M; Pawlyn C; Zweegman S; Facon T; Driessen C; Hajek R; Dimopoulos MA; Gay F; Avet-Loiseau H; Terpos E; Zojer N; Mohty M; Mateos MV; Einsele H; Delforge M; Caers J; Weisel K; Jackson G; Garderet L; Engelhardt M; van de Donk N; Leleu X; Goldschmidt H; Beksac M; Nijhof I; Abildgaard N; Bringhen S; Sonneveld P
    Leukemia; 2021 Jan; 35(1):31-44. PubMed ID: 32814840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International uniform response criteria for multiple myeloma.
    Durie BG; Harousseau JL; Miguel JS; Bladé J; Barlogie B; Anderson K; Gertz M; Dimopoulos M; Westin J; Sonneveld P; Ludwig H; Gahrton G; Beksac M; Crowley J; Belch A; Boccadaro M; Cavo M; Turesson I; Joshua D; Vesole D; Kyle R; Alexanian R; Tricot G; Attal M; Merlini G; Powles R; Richardson P; Shimizu K; Tosi P; Morgan G; Rajkumar SV;
    Leukemia; 2006 Sep; 20(9):1467-73. PubMed ID: 16855634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation.
    Durie BG; Kyle RA; Belch A; Bensinger W; Blade J; Boccadoro M; Child JA; Comenzo R; Djulbegovic B; Fantl D; Gahrton G; Harousseau JL; Hungria V; Joshua D; Ludwig H; Mehta J; Morales AR; Morgan G; Nouel A; Oken M; Powles R; Roodman D; San Miguel J; Shimizu K; Singhal S; Sirohi B; Sonneveld P; Tricot G; Van Ness B;
    Hematol J; 2003; 4(6):379-98. PubMed ID: 14671610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.